Brief: Reneo Pharmaceuticals Expects To Report That It Had About $93.8 Million Of Cash, Cash Equivalents And Short-Term Investments
May 3 (Reuters) - Reneo Pharmaceuticals Inc RPHM.O :
* RENEO PHARMACEUTICALS - EXPECTS TO REPORT THAT IT HAD
ABOUT
$93.8 MILLION OF CASH, CASH EQUIVALENTS AND SHORT-TERM
INVESTMENTS AS OF MARCH 31, 2023
Source text for Eikon: ID:
Further company coverage: RPHM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Onkure Therapeutics
See all newsBrief: Onkure Therapeutics Inc Files For Mixed Shelf Of Up To $200 Million - SEC Filing
Onkure Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Onkure Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Onkure Therapeutics Inc expected to post a loss of $1.46 a share - Earnings Preview
U.S. RESEARCH ROUNDUP-F5, Nextracker, Stryker